Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]

U.S. Patent Application 20190241896 for Modulators Of Dnm2 Expression

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Shuling GUO, Director, Doctor of Philosophy, Ionis Pharmaceuticals, Carlsbad, Antisense Drug Discovery

Isomer Separation with Vocus Ion Mobility Spectrometry - TOFWERK

WO1992005186A1 - Modified internucleoside linkages - Google Patents

WO2017053722A1 - Modulators of kras expression - Google Patents

US20190241896A1 - Modulators of dnm2 expression - Google Patents

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy

JCI Insight - Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin

Brett P. Monia's research works Ionis Pharmaceuticals, Carlsbad and other places

Clemmer Group: Indiana University Bloomington